Small Molecule Drugs and Their Use

In order for our site to display correctly you will need a newer version of your web browser.

Currently we test and support the following browsers:

FireFox version 3.0 and above (Windows and Mac)
Safari version 5.0 and above (Windows and Mac)
Internet Explorer version 7.0 and above (Windows)

Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.

Research

Technology Licensing

Small Molecule Drugs and Their Use Technologies

Anaplastic Lymphoma Kinase (ALK) Inhibitors (SJ-08-0025)

Methods for Diagnosing and Treating Learning or Mental Disorders with the SERCA2 Protein and miRNAs that regulate SERCA2 Levels (SJ-10-0003 and SJ-12-0020)

Methods for Using Reutercyclin Based Antibiotics to Treat Clostridium difficile Infections (SJ-11-0008)

New Uses for Chloroquine and Chloroquine Analogs (SJ-02-0008 and SJ-05-0017)

Novel Antibiotics and Methods of Use (SJ-97-0033)

Novel Carboxylesterase Inhibitors (SJ-02-0030)

Synthetic Natural Product Analogs as Anti-Cancer Agents (SJ-08-0026)

Treatment of Ocular Cancers with p53 Activators (SJ-06-0004 016)

Use of small molecule ER stress modulators to treat tumors with active Sonic Hedgehog (SHH) signaling due to Smoothened (SMO) mutation (SJ-12-0038)

Print Email This Article